Stephens Investment Management Group »

Halozyme Therapeutics shares owned by Stephens Investment Management Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Stephens Investment Management Group from 13F filings

Historical chart of Stephens Investment Management Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Stephens Investment Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Stephens Investment Management Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $78M 1.4M 57.24
2024-06-30 $75M 1.4M 52.36
2024-03-31 $63M 1.5M 40.68
2023-09-30 $56M 1.5M 38.20
2023-06-30 $48M 1.3M 36.07
2023-03-31 $50M 1.3M 38.19
2022-12-31 $74M 1.3M 56.98
2022-09-30 $51M 1.3M 39.54
2022-06-30 $57M 1.3M 44.00
2022-03-31 $52M 1.3M 39.88
2021-12-31 $51M 1.3M 40.21
2021-09-30 $52M 1.3M 40.68
2021-06-30 $50M 1.1M 45.41
2021-03-31 $46M 1.1M 41.69
2020-12-31 $42M 974k 42.71
2020-09-30 $7.1M 269k 26.28
2020-06-30 $4.7M 174k 26.81